Ayurveda is One of India’s Greatest Gifts to Humanity and a Trusted Partner to Modern Medicine, Says Dr. Prathap C. Reddy on the 1st National Ayurveda Day 2025

In today’s rapidly evolving and complex healthcare environment, the relevance of Ayurveda has only grown stronger. Rooted in the principles of prevention, personalization, and whole-person care, Ayurveda has pioneered a holistic model of health and wellbeing for centuries. Marking India’s first National Ayurveda Day, today, is therefore of critical significance. It comes at a time when non communicable diseases are rising, post-pandemic self-awareness about immunity and resilience is at peak, and the need for sustainable, preventive healthcare is more urgent than ever. The day underscores Ayurveda’s growing role not just as India’s cultural heritage, but as a future-ready system of medicine that aligns with national priorities in health, wellness, and economic growth.

Commemorating India’s first National Ayurveda Day, Dr. Prathap C. Reddy, Chairman, Apollo Hospitals Group in a special video message said

Ayurveda is one of the greatest gifts of India to humanity. It is renowned and respected globally as a science that goes beyond treatment, offering a complete philosophy of life with wellbeing in body-mind-spirit. From preventing and managing chronic diseases, to contributing to rehabilitation after cancer, stroke, or cardiac events, etc., Ayurveda stands as a trusted partner to modern medicine.

Through personalized lifestyle guidance, diet, mind-body practices, and detox therapies including Panchakarma, Purvakarma and Paschathkarma and other special procedures in eye-care, ENT and surgery, Ayurveda is well positioned to offer a holistic framework to tackle today’s health challenges while working in harmony with modern medicine.

Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals and Chairperson, Apollo AyurVAID Hospitals said, "The world is increasingly turning to India for its Ayurveda wisdom reflecting a growing global interest in holistic health and wellness. At Apollo, we are privileged to contribute to this movement by advancing a vision where India emerges as a global leader in preventive, promotive, and curative care across the life cycle of human beings."

Over millennia, Ayurveda has demonstrated its efficacy in managing a wide range of non-communicable and communicable disorders, including musculoskeletal & neurological disorders, digestive and respiratory ailments, metabolic disorders such as diabetes and obesity, dermatological issues, and reproductive health concerns, among many others. It has also played a vital role in managing chronic pain, boosting immunity, and correcting metabolic dysregulation, gut dysbiosis and underlying inflammation. Emerging research and patient case studies underscore the future of healthcare as true, patient-centered, integrative care.

Mr. Rajiv Vasudevan, Founder & CEO, Apollo AyurVAID, added, “For over two decades, Apollo AyurVAID has been dedicated to delivering Precision Ayurveda with an unwavering focus on safety, quality, and measurable clinical outcomes. As we enter the next decade, it is vital for stakeholders across industry, academia, research, and government to come together with a ‘patient-first’ approach, reimagining the healthcare delivery model. The future of healthcare is not about choosing one system over another; it requires a collective, integrative approach.”

This year’s theme ‘Ayurveda for People & Planet’ resonates deeply with the need for collective action to advance Ayurveda for both human and planetary wellbeing. Precision Ayurveda shall help India propel itself into the front ranks of developed nations, to become Viksit Bharat.

About Apollo AyurVAID

Apollo AyurVAID Hospitals (www.ayurvaid.com) is India’s leading chain of protocols-driven, precision Ayurveda hospitals and integrative care centres for chronic disease reversal/management, and sustained wellbeing. Since its inception in 2005, Apollo AyurVAID has been committed to transforming Ayurveda into a mainstream system of medicine with Ayurveda hospitals and clinics spread across Bengaluru, Chennai, New Delhi, Kochi, Almora and Hyderabad and soon expanding to Mumbai and other major Indian cities.

Founded in 2005 and part of the Apollo group since 2022, Apollo AyurVAID has emerged as a pivotal force in formalising Ayurveda-led integrative care, developing a unique care model that combines Ayurveda medical science with clinical rigour. The chain of hospitals has demonstrated an impactful model of seamless, integrative care across specialties including neurology, oncology, nephrology, obstetrics and gynaecology, and metabolic disorders, with a focus on adjuvant therapy, palliative care, rehabilitation. Apollo AyurVAID’s unique ‘Whole Person Care’ approach considers the whole person to treat multimorbidity, not just at symptom level but at root-cause level, and supports health across the entire life cycle, from prevention and treatment to rehabilitation, survivorship and wellbeing.

The first and only Ayurveda institution to receive the prestigious QCI DL Shah National Quality Award (2012), Apollo AyurVAID is also India’s first NABH-accredited Ayurveda hospital (2010). It is also the first to gain NABH accreditation for Ayurveda para surgery (2013) and five hospitals in its countrywide network are NABH-accredited. In 2023, it became the first and only QAI-accredited Ayurveda and integrative medicine based Transition Care Centre in India.

It has recently launched ‘Tested Safe’ Ayurveda classical medicines- a pioneering first globally whereby consumers may ascertain safety of medicine by scanning a QR code on each bottle-label and see the test report applicable to that bottle.

Apollo AyurVAID is today India’s fastest growing integrated Ayurveda health enterprise.

Reliance Retail Launches Puraveda on Tira, Marks Entry into Ayurvedic Beauty

Tira, Reliance Retail’s omni-channel beauty destination, unveils Puraveda, a progressive Ayurveda brand that marks a significant addition to its growing Own Brands portfolio. Marrying ancient Indian wisdom with the precision of modern science, Puraveda offers a fresh, transformative take on holistic beauty and wellness. Puraveda’s launch marks a significant step in Tira’s mission to bring intentional, meaningful beauty experiences to today’s conscious consumer.

Bhakti Modi, Co-founder & CEO of Tira, commented on the launch, “We are thrilled to introduce Puraveda, a brand that embodies the powerful harmony of India’s timeless wellness heritage and the precision of modern innovation. At Tira, we aim to redefine beauty by bringing forward brands that go beyond aesthetics to inspire deeper connections with self-care. With Puraveda, we invite consumers to embrace Ayurveda through thoughtfully formulated products that make holistic beauty truly accessible.”

The brand’s carefully curated portfolio is rooted in tradition yet future-forward in formulation. It spans skincare, haircare, and body care—crafted to elevate everyday rituals through cruelty-free, high-performance products.

The brand launches with a debut collection featuring over 50 products across four distinct, ingredient-led ranges:

• Dhara delivers deep nourishment, powered by Sandalwood, D-Panthenol, and Lavender
• Niyama encourages mindful rituals with Kumkumadi, Squalane, and Vetiver
• Sama fosters harmony and calm, featuring Indian Rose, Tocopherol, and Hibiscus
• Urja energises and revitalises with Mogra, BHA, and Mulethi. 

Each range is anchored in a signature synergy of Ayurvedic hero ingredients and clinically proven actives, delivering sensorial beauty experiences that are as indulgent as they are effective — a true celebration of balance, vitality, and well-being.

As Tira brings Ayurveda into the spotlight with Puraveda, it reaffirms its vision of beauty that’s as conscious as it is contemporary.The Puraveda collection will be available across Tira stores and on tirabeauty.com

Specific Foods Rich In Vitamin D According to Ayurveda

Ayurveda emphasizes natural sources of nourishment, and while it doesn’t explicitly categorize foods by vitamin content, it recognizes certain foods that support bone health, vitality, and overall strength —which aligns with modern understanding of vitamin D-rich foods.

Here are some Ayurvedic-recommended foods that naturally contain vitamin D or enhance its absorption:

• Sun-exposed mushrooms – Mushrooms, especially those exposed to sunlight, are known to contain vitamin D2.
• Ghee (clarified butter) – A staple in Ayurveda, ghee is believed to enhance nutrient absorption and contains small amounts of vitamin D.
• Milk and dairy products – Traditionally valued for their ability to nourish the body, milk, butter, and cheese contain vitamin D.
• Egg yolks – Considered a sattvic food in moderation, egg yolks provide vitamin D and support bone health.
• Fatty fish (like salmon, tuna, and sardines) – Though not strictly Ayurvedic, fish is recognized for its ability to strengthen the body and provide essential nutrients.
• Sesame seeds – While not a direct source of vitamin D, sesame seeds are rich in calcium and help support bone strength.
• Cod liver oil – Used in traditional remedies, cod liver oil is one of the richest sources of vitamin D.
• Spinach and leafy greens – While not high in vitamin D, they support calcium absorption, which works in synergy with vitamin D.

Additionally, Ayurveda emphasizes sun exposure as a crucial factor in maintaining health, as sunlight helps the body synthesize vitamin D naturally. Ayurvedic therapies like oil massages (Abhyanga) and steam treatments are also believed to enhance the skin’s ability to absorb sunlight effectively.

Ayurveda integrates the above foods mentioned with practices into daily routines with a holistic approach, ensuring that the body absorbs and utilizes nutrients effectively.

Ways to Incorporate Vitamin D-Rich Foods in Ayurvedic Routine

1. Morning Rituals & Sun Exposure: 
1. Start your day with Surya Namaskar (sun salutation), which enhances circulation and primes your body to absorb sunlight.
2. Spend at least 15–30 minutes in direct sunlight, preferably during the early morning or late afternoon hours.
2. Dietary Integration:
1. Ghee-Infused Meals: Include ghee in your diet—mixing it into dal, rice, or warm milk improves digestion and nutrient assimilation.
2. Milk and Dairy-based Preparations: Enjoy turmeric milk (golden milk) at night, or have fresh homemade paneer to nourish your system.
3. Sun-Dried Mushrooms & Leafy Greens: Add mushrooms to soups or sauté them lightly. Leafy greens like spinach and moringa pair well with sesame seeds, further aiding calcium absorption.
4. Eggs & Fatty Fish (if included in your diet): Eggs can be prepared with Ayurvedic spices like cumin and turmeric for better digestion. Fish can be balanced with cooling herbs like coriander to support digestive fire.
3. Ayurvedic Therapies for Nutrient Absorption: 
1. Abhyanga (Oil Massage): Massaging the skin with warm sesame or coconut oil helps detoxify and enhances skin health, optimizing sunlight absorption.
2. Panchakarma Detox: Occasional Ayurvedic cleansing therapies like Virechana (purgation therapy) support digestive strength, improving overall nutrient assimilation.
3. Herbal Infusions: Ayurvedic herbs like Ashwagandha and Shatavari help balance metabolism, ensuring essential nutrients are absorbed well.

Experts also highlight that urbanization, pollution, and indoor lifestyles contribute to widespread vitamin D deficiency in India

Addressing these factors through natural exposure, dietary balance, and Ayurvedic therapies can help restore optimal levels.

Tata Chemicals and BSDT’s Integrated Cancer Treatment and Research Centre (ICTRC), Pune Ink MoU to Bridge Modern Scientific Research with Traditional Ayurvedic Wisdom

Tata Chemicals Limited (TCL) a leading sustainable and science-led chemistry solutions company has signed a Memorandum of Understanding (MoU) with Bharatiya Sanskriti Darshan Trust (BSDT) – BSDT’s Integrated Cancer Treatment and Research Centre (ICTRC) in Pune. This collaboration aims to explore the beneficial effects of TCL's prebiotic, soluble dietary fibers, and their derivatives on gut health and overall wellness. This initiative underscores Tata Chemicals' and BSDT's shared commitment to delivering science-backed nutrition solutions that enhance quality of life.

The MoU was signed in the presence of Tata Chemicals' R&D team, led by Dr. Richard Lobo, and the BSDT team, led by Dr. Sushrut S. Sardeshmukh, Trustee, BSDT, and Dr. Vineeta V. Deshmukh, Deputy Director, ICTRC. This partnership will focus on integrating scientific research with Ayurvedic principles to develop advanced solutions for health and wellness.

Speaking on the occasion of signing the MoU, Dr. Richard Lobo – Head - Innovation, R&D, Business Excellence and Chief Ethics Counsellor at Tata Chemicals said "This is a momentous occasion for us as BSDT’s Integrated Cancer Treatment and Research centre's mission and its values are closely aligned with that of Tata Chemicals. We are committed to working together in understanding and improving the functionality of our science-differentiated products in Ayurvedic formulations, for improving the quality of life & alleviating pain through Ayurvedic disciplines.”

Dr. Sushrut S. Sardeshmukh, Trustee at Bharatiya Sanskriti Darshan Trust added “We are very pleased to be working closely with Tata Chemicals. At BSDT, our mission has always been to integrate Ayurveda with modern science to enhance patient care and improve quality of life. This collaboration is a significant step towards advancing research in Ayurveda integrated in wellness products with science-backed innovations. By combining our expertise in holistic healing with Tata Chemicals’ commitment to Innovative products, we aim to further explore solutions that support holistic well-being.”

BSDT, through its expertise in Ayurveda, has been instrumental in improving the quality of life and alleviating cancer-related suffering for thousands of patients. By combining Tata Chemicals’ nature-driven innovations with BSDT’s traditional healing approach, this initiative aims to advance nutritional science, expand the scope of holistic wellness, and develop impactful solutions that bridge tradition and modern healthcare advancements

D2C Ayurveda Brand Kapiva Strengthens Its R&D; Hires Dr. Govind As New Chief Innovation Officer

Kapiva Invests in Advancing Ayurvedic Research with Dr. Govind's Expertise

Dr. Govind's Appointment Signals a New Chapter in Kapiva's Research-Backed Approach

With the aim to lead the way in evidence-based Ayurveda, Kapiva, a leading holistic wellness brand announced the appointment of Dr. R Govindarajan as its Chief Innovation Officer (CIO). He is a distinguished figure in research and development, with an impressive portfolio of 10 patents and 75 research papers published in many esteemed peer-reviewed journals. He has also played pivotal roles at prestigious government research institutions like CSIR and has held leadership positions in the R&D departments of prominent organizations.

With over 23 years of experience in research and development, Dr. Govind's appointment marks a significant milestone for Kapiva. His extensive expertise and leadership will empower the brand to improve health outcomes with enhanced product quality and expand its range of Ayurvedic offerings.

Ameve Sharma, Co-Founder of Kapiva, expressed his enthusiasm about Dr. Govind's appointment, saying, "We are thrilled to welcome Dr. Govind to the Kapiva family. His extensive experience and profound knowledge of natural products and research and development are perfectly aligned with our commitment to offering authentic, science-backed Ayurvedic products to our consumers. Under Dr. Govind's leadership, we foresee taking significant strides in crafting products that are highly efficacious and will enable us to compete alongside conventional medical practices. Every step we take in our R&D initiatives brings us closer to reshaping the healthcare standards.”

Dr. R Govindarajan , the incoming Chief Innovation Officer, also shared his thoughts, stating, "I am excited to join Kapiva, a brand that is at the forefront of making Ayurveda accessible and modern. Kapiva's mission resonates with my own passion for research and innovation in the healthcare sector. I am eager to contribute to the brand's growth and help further establish Kapiva as a leader in holistic healthcare, enriching lives around the world."

Holding a Ph.D. in natural products, Dr. Govind has experience in both basic research at CSIR (Government of India) and applied research in corporate R&D through his various leadership roles at esteemed organisations such as Zydus Wellness R&D, Himalaya Global Research Centre in Dubai, and Dabur International R&D in Dubai. His work encompasses product development, analytical processes, and preclinical and clinical trials, primarily in natural products. Through his career journey, Dr. Govind has played a significant role in establishing R&D facilities globally and consulting for prominent pharmaceutical and cosmetic companies.

Beyond his corporate achievements, he has made notable contributions to academia, serving as an Associate Professor at RAK University of Health Sciences and a visiting professor at the National Institute of Pharmaceutical Education and Research (NIPER) in Ahmedabad.

Kapiva remains committed to its mission of simplifying, modernising, and making Ayurveda accessible to everyone. Dr. Govindarajan's presence will reinforce the brand’s position as a pioneer in the field of holistic healthcare.

About Kapiva:

Kapiva is a modern Ayurvedic homegrown D2C brand making Ayurveda simple, modern, and accessible for everyone and enabling everyday wellness. It is on a mission to make Ayurveda a part of people’s daily life. It offers authentic products using research, science-backed Ayurveda, and the finest ingredients. Kapiva has been a disruptor in the Ayurvedic industry by introducing innovation in product formats that can be easily integrated into people's daily routines.

The startup also announced a wholly-owned subsidiary in the US- Kapiva Inc in June 2023. It offers an innovative range of products that is popular across E-Commerce platforms and is also present on-ground in 10,500+ stores across the country.

Website: www.kapiva.in

D2C Ayurvedic Startup Dr Mantra Raises ~$200K In Funding from Sirona Founders

Dr Mantra, a D2C modelled & Ayurved-based wellness startup, has raised a bridge round of nearly $200K in funding spearheaded by 100X and backed by prominent angel investors Deep Bajaj and Mohit Bajaj, founders of leading FemTech Brand, Sirona.

The Mahuwa, Gujarat-based startup intends to utilize the funds for business growth, aiming to double its operations before pursuing a series A funding round.

Started on 2021 by Takki Zain and Shivansh Jain, Dr Mantra offers Ayurved based treatment to people suffering from lifestyle diseases such as kidney stones, piles, obesity, sexual wellness & PCOS, using 3x scientific approach, Ayurvedic products, diet plan, doctor support. The startup website reads "60% faster treatment with personalised ayurvedic approach with 93% success rate".

In a LinkedIn post, Dr Mantra Co-founder, Takki Zain, said — "After being backed by 100X.VC in Jan 2023, we scaled the revenue to 3x in just 6 months, we are again back to positive unit economics at 60 Lakhs MRR, which caught the eyeballs of Deep Bajaj."

On investment in Dr Mantra, Deep Bajaj, said - "The conviction of the founders to build this profitably is what captivated me. Those are the kind of companies which are built on customer love & trust and any team working on this is bound to be successful"

Zain further said, "...we have already impacted the lives of more than 20,000 patients & found a win-win. I am proud to say that I am a part of a purpose-driven brand that not only talks the talk but walks the walk. Thanks to our dedicated team without whom this wouldn't have been possible."

This week, Ayurvedic babycare firm BabyOrgano also raised $150K in pre-seed funding from DevX Venture Fund.

IIT Jodhpur Launches Ayurtech, A Ministry of Ayush Backed CoE to Combine Ancient Ayurveda with AI and Data Science

IIT Jodhpur has inaugurated the AyurTech Center of Excellence (CoE) sponsored by Ministry of Ayush, Government of India, combining Ayurveda and Technology to develop evidence-based solutions for precision healthcare. An initiative towards individual-centric medicine at an affordable cost using AI & data science.

Vaidya Rajesh Kotecha, secretary, Ministry of Ayush on Friday inaugurated the Ayush supported CoE at School of Artificial Intelligence and Data Science, IIT Jodhpur.

He delivered an institute lecture on Ayurveda in the digital Age: Harnessing Technology for Health and wellness, and visited the campus to understand the working of the institute.

AyurTech is being proposed as the first-of-its-kind initiative in the precision health and medicine space that would combine Electronics, Digital health and AI and multi-omics technologies for realising ‘Evidence-based Ayurveda’ solutions in a transdisciplinary framework.

IIT Jodhpur has inaugurated the #AyurTech Center of Excellence sponsored by @moayush, combining #Ayurveda & #technology to develop evidence-based solutions for precision #healthcare. An initiative towards individual-centric medicine at an affordable cost using AI & data science. pic.twitter.com/BWjHsrvoMY

— Indian Institute of Technology Jodhpur (@iitjodhpur) May 12, 2023

The new CoE aims to establish an AI-driven integrative framework for population and individual risk stratification and early actionable precision health interventions.

A built-up space of approximately 3760 sq.ft. for an AyurTech facility for Phenotyping, Molecular Biology, Chemistry and Device development fabrication and characterization area has been provided by IIT Jodhpur.

The new AyurTech facility for technological immersion will enable capacity building in different domains of Ayurveda, increase employability in transdisciplinary domain, provide innovation and entrepreneurship opportunities and help in trans-disciplinary research programs.

Vaidya Rajesh Kotecha, Hon’ble Secretary, Ministry of Ayush, Government of India, said, “I am honored to inaugurate the AyurTech Center of Excellence sponsored by the Ministry of Ayush, Government of India, at IIT Jodhpur. ‘Ayurveda Vigyaan’ is the future of healthcare system. I congratulate IIT Jodhpur for taking this initiative and hope this will help researchers in developing indigenous technologies. I am sure in the upcoming years this center will translate various research projects into successful outcomes for the betterment of the public at large.”

The Ayush Ministry is exploring how fusion of AI and Ayurveda can help in advancement of the healthcare system and the potential applications of AI in Prakriti diagnosis, phytomedicine.

Clinical Study Reveals An Ayurvedic Formulation’s Efficacy in Infertility Management; 85.23% Women Achieve Ovulation in 3 months

Gynoveda’s Ayurvedic formulation becomes an evidence-based and safe ally for women in enabling gift of motherhood

• “Clinical Evaluation of Ayurvedic Formulation Jeehv for its Ovulation Promoting Action in Females Suffering From Anovulation” by Dr. Aarati Patil, Dr. Divya C.S, and Dr. Gauri More published in the European Journal of Pharmaceutical and Medical Research
• Gynoveda’s Ayurvedic supplement were found to be effective in assisting timely ovulation and thus can be useful in the management of infertility associated with gynecological disorders like PCOS, Irregular periods etc
• The product was also found to be safe without causing any adverse effects
• Gynoveda’s Ayurvedic supplement presented a success rate of 85.23% with 127 out of the 149 participants achieving ovulation in the span of 90 days at the latest
• The clinical study is symbolic of Gynoveda’s vision of empowering women in India with an evidence-based medicinal system that delivers on-ground and tangible impact in women's healthcare by harnessing the power of Ayurveda

Gynoveda.com, an Ayurveda-backed women healthcare brand has taken a significant stride for women dealing with infertility issues. Its Ayurvedic supplement, recognized by European Journal of Pharmaceutical and Medical Research, was found to be effective in assisting timely ovulation and thus can be useful in the management of infertility associated with gynecological disorders like PCOS, Irregular periods etc. Conducted at Dhanwantari Ayurveda Centre, Pallakad, Kerala, India and amongst 149 participants (age group - 25-35 years) across India, the study reported 85.23% women achieving ovulation on time after consuming the Gynoveda’s Ayurvedic supplement (within 3 months). Moreover, no adverse drug reaction was observed offering women an opportunity to experience a safe motherhood.

Dr. Aarati Patil (MD, Ayurveda Gynaecology), Chief Doctor, Co-founder, and R&D Head, Gynoveda speaking about the breakthrough Ayurvedic formulation says, “With 15 years of experience in providing treatment to women grappling with severe gynecological disorders such as PCOS, fibroid, infertility, and endometriosis, I and my team are elated to have introduced a groundbreaking Ayurvedic supplement that possesses the potential to alleviate these disorders and conceive naturally.”

Gynoveda's Ayurvedic supplement has proven to be instrumental in assisting thousands of women in overcoming complications and achieving natural conception. This research paper is a testimony to Gynoveda’s mission to enable women to embrace the gift of motherhood.

Across the nation, women have enthusiastically shared their success stories, highlighting the efficacy of Gynoveda in their journey towards motherhood.

Gynoveda Co-founders (R- L) — Rachana, Vishal, Aarati

Sneha Chourasia from Madhya Pradesh says, "After seven years of marriage, I found success in conceiving with the help of Gynoveda. When I consulted doctors, they diagnosed me with PCOS, which made my journey to pregnancy more complicated. I tried different conventional methods to conceive, but they proved to be long and unsuccessful. As a last resort, I decided to give Gynoveda’s Ayurvedic supplement a try, incorporating it into my daily routine. To my delight, It worked its magic, enabling me to conceive naturally”

Minni Sharma from Lucknow says, “I spoke to gynaecologists and they told me about follicular study. They suggested inducing forceful ovulation injections; which was a very painful and an expensive process for me. I came across Gynoveda’s Ayurvedic supplement which is much more cost effective and efficient. Within just six months of incorporating it into my routine, I conceived naturally “

Abha Kumari from Patna says, "I can personally vouch for the remarkable benefits of Gynoveda’s Ayurvedic supplement when it comes to overcoming complex pregnancy challenges. Despite being diagnosed with fallopian tubal blockage, poor egg quality, and an ovarian cyst, I refused to give up. After trying various medical interventions, including the lengthy and fruitless process of IUI, I turned to Ayurveda supplement as my last hope. Incorporating it into my daily routine allowed me to conceive naturally “

Chetna Jain from Mumbai says, “Gynoveda’s 3x program which includes Diet, Medicine and Doctor support is an all rounded plan that helped me in my journey of a successful pregnancy. Before turning to Ayurveda, I opted for IVF and it did not give me the result I was hoping for. As a last resort, I incorporated Gynoveda’s Ayurvedic supplement in my daily routine and it helped me conceive naturally and give birth to a healthy baby”. 

Sunayani Bhowmik from Bangalore, whilst carrying her one and a half day old baby in her arms says, "Throughout my pursuit of a successful pregnancy, I explored the realms of allopathy and homeopathy for assistance. Unfortunately, these avenues failed to yield positive results. As a last recourse, I discovered Gynoveda's Ayurvedic supplement. To my delight, the initial evaluation following my utilization of Gynoveda’s supplement showcased a reduction in cystic growth. First thing I noticed after 2 months was that I had started having my regular period cycle and then I started taking PCOD pills religiously for two years."

Furthermore, the study also reported that 123 women(82.55%) had complaints of irregular menstrual cycle which was normalized in 98 women. No adverse drug reactions were observed and the study products were well tolerated.

Despite being informed that conceiving would be unattainable, women who had spent significant time and resources on modern medicine were able to fulfill their dream of motherhood through the Gynoveda’s breakthrough Ayurvedic supplement. Gynoveda proudly celebrates mothers and mothers-to-be with their continuous effort.

About Gynoveda

Gynoveda is the World’s first Ayurveda FemTech brand. It combines Ayurveda, Technology, Content & Community for women's healthcare, especially menstruation. Husband-wife duo Rachana & Vishal Gupta as founders of Gynoveda are on a mission to make Ayurveda as world’s first choice for women’s health from puberty to menopause. Gynoveda’s ayurvedic proprietary medicines with FDA approval have helped over 4 lakh women treat the root cause of disorders related to PCOS, irregular periods, infertility, pregnancy, skin, hair & general wellness. The company has delivered over 2 lakh orders across 20,000 pincodes in 58 major cities.

The company raised $10 million in March 2023 in Series A funding led by India Alternatives Fund. Since then its e-commerce platform Gynoveda.com is growing rapidly at 25% month-on-month and it's on track to cross ₹100 crores ARR in the current financial year. Gynoveda founders along with a team of doctors & scientists invented the world’s first Period Test, a gynecology bot that uses artificial intelligence (AI) to self-diagnose her reproductive health by answering a few questions on her mobile in just 2 minutes and getting results instantly.

Ayurveda-backed Women's Healthcare Startup Gynoveda Raises $10 Mn in Series A Funding Led by India Alternatives Fund

Ayurveda-enabled curative solutions from puberty to menopause for 1 Million women of India

Round also saw participation from Wipro Enterprises, RPG Ventures, Dharampal Satyapal Ltd, and Alteria Capital amongst others. Existing investor Fireside Ventures, who had earlier invested $1 million as seed capital in Oct 2019, also participated in this round.

Gynoveda, an Ayurveda-backed women’s healthcare startup, has raised $10M in Series A funding led by India Alternatives Fund. The round also saw participation from reputed family offices and institutions including Wipro Enterprises, RPG Ventures, Dharampal Satyapal Ltd, and Alteria Capital. Existing investor Fireside Ventures, India’s leading early-stage venture capital fund, which had earlier invested $1 million as seed capital in Oct 2019, also participated in this round showcasing its continued belief in Gynoveda’s vision.

Gynoveda, founded in 2019 by the husband-wife duo - Rachana & Vishal Gupta and Dr. Aarati Patil aims to democratise Ayurveda-enabled, curative self-care solutions for gynaecological and lifestyle-related disorders women face from puberty to menopause.

With the help of this funding, the company aims to raise awareness about the importance of menstrual health on a grassroot level, making Ayurveda the first choice for women’s healthcare. Hence, the funds will be deployed to double down on strengthening R&D, formulating new ayurvedic offerings, onboarding talent, expanding distribution channels and increasing brand awareness. Currently, empowering women via D2C channels like the website, and e-commerce marketplaces, Gynoveda plans to step into the offline domain in the near future to reach women across the breadth and depth of India.

In a statement, the company Founder & CEO, Vishal Gupta, said that “Gynoveda has so far improved the health of 3 lakh women residing in 20,000 pincodes of India. This led to the company tripling its revenue year-on-year between FY20 and FY23 to reach ₹100 crores annual revenue run rate within 3 years of its inception. Gynoveda is on a mission to change the lives of 1 million women, which is still a fraction of the billion women worldwide that need this unique ayurvedic solution."

Shivani Bhasin Sachdeva, Founder, Managing Director, and CEO of the India Alternatives Private Equity Fund, said, “This investment fits perfectly with our investment themes of Women & Health. Today, over 40% of online shoppers are women, up from 10% a few years ago. Women’s health globally is an underserved market. We are proud to back a company that uses an age-old science like Ayurveda in a new format to provide solutions for this large addressable market."

Vinay Singh, Partner, Fireside Ventures, said, “Gynoveda’s disruptive vision combined with research-backed solutions is enabling it to bring tangible change in the lives of women. We are very impressed with how Vishal, Rachana & Dr. Aarati are building a robust healthcare stack for menstrual & reproductive health. We are glad to be a partner in their journey to completely transform women's healthcare ecosystem, ground up”

The Offering and Success

Gynoveda aims to revolutionise the $9.6 billion global women's healthcare industry by being the first player to introduce Ayurveda as a solution to solve complex gynaecological disorders. Gynoveda’s ayurvedic proprietary medicines certified by FDA & NABL, help treat the root cause of more than 20+ period disorders including PCOS, Infertility, irregular periods, vaginal health and much more. Where modern medicines offer only temporary relief, Ayurveda promises safe solutions to experience hassle-free periods lifelong.

The company has tripled its gross revenue year-on-year between FY20 and FY23 to reach INR 100 crores annual revenue run rate within 3 years of its inception. The google rating of 4.8 further reflects the growing customer love and trust by over 3 lakh women spread across 20,000 pincodes in India.

Past Funding & Team

In their Seed round, Gynoveda had raised a $1 million amount led by Fireside Ventures. In 2022, Bollywood actor Tapsee Pannu joined the brand’s mission as a brand ambassador.

Founded by Vishal & Rachana Gupta in 2019, who were later joined by Dr. Aarati Patil {M.D Obstetrics & Gynecology (Ayu)} the brand aims to transform the way gynaecological disorders are treated. Currently a team of 50+ members strong, it combines ayurveda, technology, content, and community for women’s healthcare.

About Gynoveda

Gynoveda is the World’s first Ayurveda FemTech brand. It combines Ayurveda, Technology, Content & Community for women's healthcare, primarily for menstrual & reproductive health.

Husband-wife duo Rachana & Vishal Gupta as founders of Gynoveda are on a mission to make Ayurveda as world’s first choice for women’s health from puberty to menopause. Gynoveda’s ayurvedic proprietary medicines with FDA approval have helped over 3 lakh women treat the root cause of disorders related to PCOS, irregular periods, infertility, vaginal health & overall welnness. The company has delivered over 4 lakh orders across 20,000 pincodes in more than 50 major cities.

The company raised $1 million in November 2019 from early-stage investment firm, Fireside Ventures. Since then its e-commerce platform Gynoveda.com is growing rapidly at 25% month-on-month and it's on track to cross ₹100 crores ARR in the current financial year.

Gynoveda founders along with a team of doctors & scientists invented the world’s first Period Test, a gynaecology bot that uses artificial intelligence (AI) to enable women self-diagnose her reproductive health by answering a few questions on her mobile in just 2 minutes and getting results instantly.

Mankind Pharma Acquires Majority Stake in Upakarma Ayurveda

Manknd Pharma Limited has announced that one of its subsidiaries has acquired a majority stake in Upakarma Ayurveda Private Limited, a brand that is engaged in developing, manufacturing and selling ayurvedic and herbal products.

Upakarma Ayurveda offers products ranging from improving health and wellness to boosting immunity. It is driven by the vision to achieve overall well-being of the human body with a focus on body, mind, and lifestyle.

Upakarma Ayurveda has repositioned Shilajit as a health & wellness product, and sought to reimagine the stereotypical way Shilajit was perceived in the market as an aphrodisiac (sexual wellness product) for men. Upakarma Ayurveda has elucidated the cumulative benefits of Shilajit as an overall health rejuvenator and immunity booster.

Mankind Pharma’s decision to invest in Upakarma Ayurveda will empower the latter to strive to develop a wider range of products and offerings and penetrate the market leveraging the strong distribution network of Mankind Pharma.

On the occasion, Rajeev Juneja, the Vice Chairman and Managing Director of Mankind Pharma Limited, said, “The current lifestyle has become strenuous where people find it difficult to focus on their health. To fulfill their requirements, consumers are considering Ayurvedic remedies for long-term sustenance and boosting immunity over time. As Mankind Pharma works towards improving the healthcare of people, we have associated with Upakarma Ayurveda in order to cater to the emerging needs of consumers.”.

Being optimistic Vishal Kaushik the Founder & Managing Director of Upakarma Ayurveda said, “There has been a rising consciousness around Ayurveda in recent years. We, at Upakarma Ayurveda, have been building a connection with our consumers, and now with this partnership, the team is elated and is looking forward to widening our reach with Mankind Pharma backing us. With this partnership, I along with my co-founder, Parag Kaushik, are hopeful that quality ayurvedic solutions will reach far and wide”.

HempStreet Expands Product Portfolio, Launches Sarpagandha Vati, to Combat Hypertension

HempStreet, India's first research to retail venture in the ayurvedic cannabis sector, has launched Sarpagandha Vati. Coming in the form of a tablet, Sarpagandha Vati helps treat Hypertension and Insomnia due to its calmative properties.

HempStreet’s dispensation works through a network of doctors who can buy the product via HempStreet’s B2B channels. This medicine is safe and reliable for middle and even old age people (39-70 years) who are at higher risk of side effects. The classical ayurvedic formulation outperforms other drugs in the same therapeutic range when combined with more potent herbs such as Vijaya (Cannabis Sativa) and Jatamansi (Nardostachys Jatamansi).

Each tablet of ‘Sarpagandha Vati’ contains Sarpagandha (262.20 mg), Khurasani Ajwain (52.44 mg), Jatamansi (26.22 mg), Vijaya (26.22 mg) and Pipalimula (4.92 mg). This Ayurvedic medicine calms the nervous system, aids in the maintenance of normal blood pressure, and maintains oxygen balance that helps regulate blood pressure in hypertensive patients. Additionally, Sarpagandha Vati’s diuretic and detoxifying properties benefit people with the following health and lifestyle issues:

• Help manage Epilepsy and Delirium
• Help combat anxiety disorder
• Help curb the desire for Alcohol
• Induce natural sleep to defy Insomnia

While conventional medications have serious health consequences, Ayurveda offers a natural, holistic, safe, and effective alternative to alleviate the condition of Hypertension. Sarpagandha Vati aims at providing a reliable and safe ayurvedic solution to hypertensive patients by regulating their blood pressure.

About HempStreet

HempStreet is India's first research to retail medicinal cannabis venture, working towards amalgamating the age-old science of Ayurveda with modern cannabis research to develop sustainable and economical solutions for mass ailments. All of this while ensuring end-to-end blockchain technology-based supply chain tracking to minimize any chance of abuse. HempStreet's dispensation network of more than 11000 partner clinics across 26 states of India is a testament to the efficacy of the formulations and the trust of medical practitioners in the brand. 

The company is also India's first medicinal cannabis venture to have been awarded the prestigious Biotechnology Ignition Grant (BIG) of BIRAC. Recently HempStreet partnered with Gynica, an R&D company based out of Israel focused on changing the culture of gynecological treatment through clinically proven, cannabinoid-based solutions.

Medical Cannabis Startup Hempstreet and Amrita School of Ayurveda Tie-Up to Fight Against Mass Ailments

Through this partnership, HempStreet aims to build solutions to help them in their fight against mass ailments.

HempStreet, India's first research to retail venture in the ayurvedic cannabis sector, has partnered with Amrita School of Ayurveda. Amrita School of Ayurveda, based in Kerala, was founded in 2004 and is a well-known Ayurvedic education facility both nationally and internationally. Through this collaboration, HempStreet aims to receive clinically supported solutions to aid in their fight against mass ailments.

HempStreet started with the vision to harness the power of ayurveda and utilize responsibly dispensed cannabis based medication to tackle chronic ailments. HempStreet’s partnership with Amrita School of Ayurveda is one step further to meet the nation's needs of managing ailments through modern Ayurveda. Amrita School of Ayurveda, part of Amrita University, is ranked fifth in the National Institutional Ranking Framework (NIRF) Rankings 2021. Amrita School takes a unique approach to blending ancient philosophies and health science by cultivating a new breed of Ayurvedic physicians to fulfill the mission of creating a patient-centered and integrated health care delivery system.

Commenting on the partnership, Abhishek Mohan, Founder & CEO, HempStreet, said, “We are very excited to announce this partnership with Amrita School of Ayurveda and its affiliate R&D organizations to work towards clinical validation of formulations to address several mass ailments. This aligns with our policy of partnering with the best in class. With this partnership, we strive to further our mission to harness the power of Ayurveda via cannabis-based medication with a layer of clinical validation. This fits our global strategy of best-in-class partnerships across Europe, the US and Israel.”

Adding to this, Dr P. Ram Manohar, Head, Centre for Advanced Research In Ayurveda (ACARA), said, "We are thrilled to be collaborating with HempStreet. Our goal is to promote the expansion and advancement of Ayurvedic education, and working with HempStreet will help us close the knowledge gap between cutting-edge technological advancements and traditional medicine based on ancient wisdom. By bringing tradition and scientific research together, we can pave the way for contemporizing Ayurveda to meet global health care needs.”

HempStreet is poised to reshape the way mass ailments are addressed by raising awareness about the use of cannabis for pain management to address one of the health sector's most pressing issues. The company recently collaborated with over 400 Ayurvedic doctors in Mumbai to bolster this. Furthermore, to strengthen the R&D and distribution segment, HempStreet also partnered with MGC Pharma and Gynica earlier this year.

About HempStreet

HempStreet is India's first research to retail medicinal cannabis venture, working towards amalgamating the age-old science of Ayurveda with modern cannabis research to develop sustainable and economical solutions for mass ailments. All of this while ensuring end-to-end blockchain technology-based supply chain tracking to minimize any chance of abuse. HempStreet's dispensation network of more than 11000 partner clinics across 26 states of India is a testament to the efficacy of the formulations and the trust of medical practitioners in the brand. The company is also India's first medicinal cannabis venture to have been awarded the prestigious Biotechnology Ignition Grant (BIG) of BIRAC. Recently HempStreet partnered with Gynica, an R&D company based out of Israel focused on changing the culture of gynecological treatment through clinically proven, cannabinoid-based solutions.

About Amrita School of Ayurveda:

Amrita School of Ayurveda, Amritapuri was established in 2004 and managed by Mata Amritanandamayi Math Trust. The college has developed into a prestigious centre for education in Ayurveda, nationally as well as internationally, under the gracious guidance of its founder and spiritual guru, Mata Amritanandamayi Devi. The mission of the school is to provide a value-based education and mold the character of our younger generation through synergy of science and spirituality so that their earnest endeavor to achieve progress and prosperity in life is matched by an ardent desire to extend selfless service to the society, one complementing the other.

Zeon Lifesciences and Pharma Varsity DPSRU Ink MoU for Innovation in Nutraceuticals, Phytopharmaceuticals and Ayurveda

Zeon Lifesciences signs MoU with Delhi Pharmaceutical Sciences & Research University (DPSRU)

Aim to accelerate the development of new breakthroughs in the fields of nutraceuticals, phytopharmaceuticals, and Ayurveda

Zeon Lifesciences, India’s largest manufacturer of Nutraceutical and Herbal products, signs a Memorandum of Understanding (MoU) with Delhi Pharmaceutical Sciences & Research University (DPSRU) to establish collaboration for academic interaction and research advancement in the specified fields, as well as to share facilities and expertise. 

DPSRU and Zeon will conduct collaborative research activities at DPSRU encompassing pharmaceutical technology, synthesis and analytical techniques, pharmacotherapeutics, standardization of herbal actives and protocols adopted to comply with the regulatory milieu of the region/country concerned.

The goal of this collaboration is to conduct R&D projects to investigate formulation and product development in the fields of nutraceuticals, phytopharmaceuticals, and Ayurveda. Zeon Lifesciences Limited and DPSRU will be conducting clinical trials as per AYUSH or DCGI guidelines, applicable for selected formulations. Both entities will also conduct studies to compare the prevailing regulations, approaches and challenges while registration of drug products.

Commenting on the collaboration, Mr Suresh Garg, MD and Founder, Zeon Lifesciences: “Our collaboration with DSPRU aims to give our country's youth hands-on experience with the industry's ongoing development in the nutraceutical and phytopharmaceutical sectors. Millennials will have the opportunity to delve deeply because there has been an increase in curiosity, and as a result, they will grow rapidly in this field. We anticipate strong alliances, both domestically and globally.”

"We're looking forward to collaborating with Zeon Lifesciences on joint convergence research projects, as well as establishing and operating leading academic models in the emerging fields of nutraceuticals, phytopharmaceuticals, and Ayurveda. This collaboration will help both parties combine their complementary strengths and work towards establishing a thriving ecosystem for the future." Dr Ramesh Goyal, Vice-Chancellor, DPSRU added. 

With the vision to transform into a research-driven organisation, Zeon has collaborated with multiple reputed institutions across India for conducting quality research, pre-clinical & clinical study on these products, including NII, New Delhi, CCMB Hyderabad, IMS, Banaras Hindu University, SRM University, Chennai, Adesh University, Punjab, BITS Pilani, NIPER Mohali, and IIIM, CSIR, Jammu. Zeon has expressed an interest in collaborating on a variety of research-based products and technologies for the development of novel formulations and drug discovery.

Incubation Centre for Startups in Ayurveda Sector Launching on Friday

India's Ayush Minister, Mr. Sarbananda Sonowal, will inaugurate the Incubation Centre for Innovation and Entrepreneurship (AIIA- iCAINE) at All India Institute of Ayurveda (AIIA), on Friday (29th Oct 2021) at a program organized in Vigyan Bhavan, New Delhi.

To promote entrepreneurship leveraging the academic knowledge, All India Institute of Ayurveda (AIIA), has set up an Incubation and Innovation Centre in its campus to nucleate a cluster of new age ventures. 

AIIA has been recognized as Host Institute (HI) under Ministry of Micro, Small & Medium Enterprises (MSME), Government of India which would provide opportunities to the innovators in developing and nurturing their ideas.

The incubation centre will be set up under the mandate of Ministry of Ayush given to AIIA to nucleate a cluster of new age ventures and to promote entrepreneurship leveraging the academic knowledge. "Startups are new types of wealth creators in our country", Prime Minister Narendra Modi said in his Independence Day speech on 15 August, 2021, underscoring the need of the government to relentlessly work towards making India’s Startups and the Startup Ecosystem, the best in the world. Government of India is implementing Centrally Sponsored Scheme of National AYUSH Mission (NAM) through States/UTs for development and promotion of AYUSH system of medicine.

A national seminar on "Start-ups in Ayush Sector- Scope and Opportunities (AYUR-UDYAMAH)” is also being organized on 30th October as a part of the program. 

The event will witness representatives from Ayurveda Sector across the country, and about 400 AYUSH institutes and MoU partners working in collaboration with AIIA.

In August, it was announced that World's first Bio-Bank of Ayurveda will be established at AIIA. 

On 30th Oct 2021, during National seminar at AIIA campus, Eminent Speakers from Ministry of Ayush, Ministry of Commerce and Industry, Ministry of Food Processing Industries, Ministry of Micro, Small & Medium Enterprises (MSME), IIT, NCISM, NIFTEM, Food Technologists, Entrepreneurs will be sharing their expertise. An Ayurveda Food Expo will also be organized during the event to exhibit strength of Ayurveda in Food Sector.

The event will also include Launch of Qualification Packs for AYUSH Sub Sector Skill Council under Health Sector Skill Council (HSCC). AIIA is acting as a nodal organization under the directions of Ministry of AYUSH in the execution of skill development programs in AYUSH sector since 2018 and the Ministry has designated AIIA as the centre of excellence in skill development under HSSC.

Health and Wellness Brand NatureCode(R) Forays into India Market

Launches new range of Dry herbs and Ayurvedic Wellness products

New Delhi, August 9, 2021: Delhi based NatureCode, announced its foray into the Indian market with range of Ayurvedic wellness products and Dry Herbs. NatureCode – Love Nature, Love your Health™, was introduced with a prospective of delivering natural methods that always take longer to show the results but they aren’t temporary solutions, they promise their lifelong companionship.

NatureCode has a beautiful collection of Ayurvedic Wellness products, these products are developed to help treat existing wellness issues and to put a stop to future concerns. These products are effective and have good results as they combine with herbs & herbs extract for more efficacy. The brand is all about Ayurveda products such as Immunosoul - Immunity Booster, Diabasoul - Blood Sugar Management Supplement, Livsoul - To protect liver, Slimsoul - Body Weight Management supplement, Jointrep - To cure Joint pains, Vitasoul- Vitality Booster etc.

NatureCode also has Dry extract Herbs like Brahmi,Neem, Moringa, Tulsi, Giloya, Amla, Mulberry, Green Tea, Green Coffee, Garcinia Cambogia, Shilajit and Safed Musli etc.

Vani Ahuja Co-Founder & Director says, “Our main motive behind launching NatureCode in India is that we always wanted to fill the gap between the International market and the Indian market in terms of Ayurveda & Naturalism. As a result of our long research about how we can fill this gap with, we understood the powers of Ayurveda - Ayurveda is known as a lifestyle more than a medicinal practice. Leading an Ayurvedic lifestyle is an assurance for a long and healthy life. Ayurvedic products are made using the best of nature, and hence, they are harmless and free of side effects.”

The main benefit of the brand is that the product range helps dealing with anything that a child or an adult would require in their lives. There is utterly no yearning of ours that nature cannot suffice.NatureCode honour Mother Nature by accepting her gifts and weaving their magic on them. We use Earth’s divine offerings to create sacred products that resonate with the deepest values and roots of humankind.

Pricing and Availability

NatureCode’s health supplements are reasonably priced ranging from INR 200 to INR 2500. The products are available on company’s official website www.naturecodeindia.com in domestic markets and all leading e-commerce portals including, 1mg, Amazon, Flipkart, and Snapdeal, etc.

About NatureCode

Delhi based start-up NatureCode is a Natural and Modern Ayurveda cosmeceuticals, wellness and health supplement products brand. NatureCode’s products are vegetarian and prepared freshly in company’s own manufacturing unit using standardized herbal extracts for consistent quality and efficacy and are Ministry of Ayush Certified, Pure & Potent, Cruelty-Free, Vegan, Gluten, Artificial Colour & Flavour free. The products cover various health benefits of traditionally-proven herbs aimed at fulfilling the daily health needs and thereby restoring wellness and good health.

Soon World’s 1st Bio-Bank of Ayurveda at AIIA, Delhi

Recently, India’s first bio-bank for heart failure research was inaugurated at Kerala's Sree Chitra Tirunal Institute for Medical Sciences and Technology, which is established as a guide to future therapies. Now, in a latest, Union Ayush Minister Shri Sarbananda Sonowal along with Minister of State for Ayush, Dr. Munjapara Mahendrabhai has assured all help for establishing the first Bio-Bank of the world in Ayurveda at All India Institute of Ayurveda (AIIA) located in Delhi .

Both the Ministers highly appreciated the work done by AIIA and assured their full-fledged support for further development of the Institute to make it world’s best Ayurveda Institute. The ministers were there for inaugurating Multi-Purpose Yoga Hall & Mini Auditorium.

Established in 2015 as a first AIIMS-like institution on Ayurveda, AIIA aims at bringing a synergy between Traditional Wisdom of Ayurveda and Modern tools and technology.

The institute also offers postgraduate and doctoral courses in various disciplines of Ayurveda and will focus on fundamental research of Ayurveda, drug development, standardization, quality control, safety evaluation and scientific validation of Ayurvedic medicine.

The Ayurveda Co. Raises Undisclosed Amount from GetVantage, Velocity, and Shiprocket C​​apital

The Ayurveda Company (TAC) – India’s First Science Backed Ayurveda, has raised an undisclosed amount in various rounds of funding from GetVantage, Velocity, and Shiprocket Capital through revenue-based financing. The company will deploy these investments for growth marketing, inventory capital and employee/ workplace benefits. The brand aims to target the growing digital consumers of India in the D2C personal care space. The company is the second venture of founders Param and Shreedha after the success of their first entrepreneurial endeavor Khadi Essentials (KE) Healthcare Pvt. Ltd.

"Amalgamating the vision of TAC with learnings of Khadi Essentials, our dream is to create an international D2C Ayurvedic entity for the global millennials. Being entirely bootstrapped. KE’s revenue had been the primary source of TAC’S funds. Our idea is to bring out unique, innovative & concern led products in the skincare and haircare range that are a perfect blend of Ayurvedic principles and naturally derived scientific formulation and eventually extend the product portfolio into the wellness and nutrition domains. We are preparing ourselves to become India’s Fastest growing D2C Beauty & Wellness Brand and this partnership with our RBF friends will help us in giving the right launchpad to TAC before the Pre Series A round. ” said Param Bhargava – Founder – The Ayurveda Company (TAC)

TAC products have been attractively priced to ensure that they cater to a really large and global (specifically in the US, Europe, Australia and the Middle-East) consumer base. It is also slated to enter international markets very soon. This outreach to global audiences is likely to be one of the biggest developments for TAC. Further, there has also been a greater emphasis on making TAC’s D2C webstore to generate higher revenues for the organization.

“We are working on multiple unique SKUs for the next 4 quarters with launches across beauty and personal care, natural makeup and wellness & nutrition that are scheduled to take place very soon taking our Portfolio to 100 Unique SKUs. We began with a team of 3 in January 2020. This number grew to 20 in July and eventually 60+ members in July 2021. By the end of this financial year, the TAC family is likely to grow even further and become 100 members strong,” said Shreedha Singh – Co-Founder – The Ayurveda Company (TAC)

Ensuring complete quality control is at the very core of TAC’s ethos with the highest benchmarked quality standards. Its cruelty free products with no sulfates, parabens and other harmful chemicals make it a rightly priced brand with the right products. Launched in April 2021, TAC has been steadily moving towards the ambition of becoming a loved and fast-growing Ayurveda brand. By the end of the first quarter, TAC managed to reflect a monthly run-rate of USD 70K. In the first 3 months of launching its product catalog, TAC is available on all online marketplaces, including Amazon, Nykaa, Tata CLIQ, Purplle, and Myntra along with its own webstore (www.theayurvedaco.com). Within 3 months TAC has become one of the fastest growing Brand on India’s most loved beauty destination Nykaa & is already in top 35 Natural Brands. The vision for the company is to become a global brand within the Ayurveda sector and help and promote adoption of Ayurveda by one and all.

Creating a perfect synergy between ayurvedic wisdom and modern medical science, TAC uses the highest quality, ayurvedically derived, naturally extracted, and scientifically formulated ingredients while keeping them priced within a premium-economy range. The intention is to effectively build a much-needed middle-ground blending Ayurvedic wisdom with scientific R&D, thus innovating products that despite being plant-based and organic, yield quicker results. “In the next 3-5 years, we aim to cover the holistic portfolio of the Ayurvedic lifestyle while keeping it contemporary. We understand this business well and possess huge data insights for the right product roadmap. Along with being extremely consumer & data centric we also love building and working with Technology, we are building a world class app to engage our consumers and provide Ayurvedic Consultation in the future,” said Param Bhargava.

About Company

KE Healthcare Private Limited was founded in 2019 by Shreedha Singh and Param Bhargava, It's a house of the brand under which In 2019, they launched Khadi Essentials, a beauty, and wellness brand followed by The Ayurveda Co. in 2021.

Two young Entrepreneurs Launch India’s 1st Ayurveda-Inspired Functional Chocolate Brand

AWSUM is India’s first functional chocolate brand for millennials who are dealing with modern-day lifestyle disorders like stress, mid-day lethargy insomnia, depression, etc.

Amid the COVID-19 pandemic, when immunity boosters are driving people crazy, one would not be able to assimilate the fact that Chocolates can also boost your immunity and can be made of Ayurvedic herbs and botanicals.

The pandemic forced the urban workforce to quickly adapt to the remote working model. As a result of working from home, the lines between professional and personal life began to get blurry. The millennials, who love to eat out, shop, and travel, were now confined to their rooms. The increased screen time hampered their circadian rhythm due to which they are struggling to get a good night sleep. This has also led to a surge in disorders like stress, insomnia, mid-day lethargy, depression and other ailments.

Designed to help the urban working millennials deal with their modern-day lifestyle disorders, two friends Pranav Sharma and Kritik Thakur, have launched India’s first Functional Chocolate brand, Awsum. Awsum is first of its kind chocolate brand which is using Ayurvedic principles to make products healthier that nowhere compromises on taste. Awsum uses the ancient wisdom of Ayurveda and combines it with premium dark and milk chocolate to create exciting products that come with functional benefits.

The Functional Chocolate as a category is very new and novel for the Indian markets with no similar brands available in the same space. These Chocolates are packed with herbs and nutrients that help the body to deal with the modern-day lifestyle health disorders and are very relevant for the current scenario where we are all dealing with a pandemic like COVID. The chocolates have a rich and smooth texture and do not come at a compromise of taste.

Awsum has initially launched 4 variants to start off with which are: Daily Energy, Sleep, Goodbye Stress and Active Immunity.

“The mission of the brand is to inspire lifelong healthy habits by bringing simplicity, inspiration and delight to the world of supplements and nutraceuticals. These functional chocolates immensely help you to fight and deal with modern day lifestyle problems- from sleep deprivation to stress and anxiety. So, a product like this has become all the way more relevant in the current scenario where India is fighting a battle with a global pandemic, wherein everyone is looking for immunity boosting products and problems like sleep deprivation stress and anxiety has aggravated all the way more”, said the Co-founders, Pranav Sharma and Kritik Thakur.

The idea of Awsum was conceived in the backdrop of nationwide lockdown declared by the government last year in 2020 when the co-founders themselves grappled with problems such as sleep deprivation, daytime lethargy, and anxiety. And their own experience led to the creation of the brand that aims to help people deal with these problems in a more convenient and an exciting way. Their ‘Awsum’ thought took shape at Gurugram based start-up incubator, Huddle that closely works with selected high-growth start-ups. The company is also backed and mentored by a group of highly accomplished individuals and industry experts.

People irrespective of class, gender, region, love chocolates, and many medical researchers have already proved that they are a good source of antioxidants. Awsum just gave us more reasons to munch chocolates and compensate for vitamins, minerals, and other nutrients.

Website: www.awsum.life

Aurea Biolabs Launches PureVeda, a First-of-Its Kind Nutraceuticals Range for Health Conscious Individuals in India

PureVeda Nutraceuticals Range - Activ Digest, Super Turmeric and Tru Relief

Aurea Biolabs, a leading manufacturer and exporter for nutraceuticals, today announced the launch of PureVeda, - a first-of-its kind nutraceuticals range in India. Clinically proven to deliver unmatched efficacy, the PureVeda range of nutraceuticals comprises of Super Turmeric (for Wellness and Immunity), Tru Relief (for Pain Management) and Activ Digest (for Digestive Support).

 
The PureVeda range of products are potent capsules of health that are crafted from 100 % pure and natural ingredients. They have been formulated using the unique concept of the Golden Triangle – which essentially involves combining the knowledge of Ayurvedic science with Aurea Biolabs’ patent filed delivery technologies (PNS and Zeal) and are backed with clinical evidence.
 
PNS and Zeal are a one-of-its-kind, patent filed formulation technology that helps in deriving the maximum benefit of a natural ingredient. PNS (Polar–Non-polar sandwiching) is a process which makes natural molecules highly absorbable in the intestinal tract, consequently increasing its bioavailability, while Zeal ensures maximum efficacy, potency, and bioavailability with a highly efficient, targeted delivery system.
 
John Nechupadom, Managing Director of Aurea Biolabs, stated, “We are seeing a paradigm shift in the way Indians perceive health and wellness, with the number of health conscious individuals growing rapidly each year. They are turning to alternatives that not just address specific health needs but also act as a daily fulfilment to keep up with a fast paced life. More importantly, they are looking at convenient and natural health solutions that are pure, effective and have a lasting impact on overall health and wellbeing. The genesis of PureVeda was rooted in these insights. The PureVeda range of nutraceuticals have been conceptualized and developed to meet the dynamic lifestyle of the health conscious Indian, while being globally competitive in safety and performance.”
 
“At Aurea Biolabs, we have always been committed to developing quality health and wellness solutions. Using our deep knowledge around botanicals, along with our patent filed PNS and Zeal technologies, the PureVeda range of products have been extensively validated through pre-clinical and clinical studies to deliver higher absorption and efficacy in the human body. We are confident, that our new range of products will gain wide acceptance across the country,” added Sasikumar Kuttappan, Ph.D, Chief Scientific Officer.
 
The PureVeda range of nutraceuticals – Super Turmeric, Tru Relief and Activ Digest, have been developed using safe, sustainable and high-quality ingredients.
 
Super Turmeric is a full spectrum natural supplement that incorporates over 200+ bioactive molecules of the turmeric rhizome, with the highest percentage of curcuminoids. Supported by 7 clinical trials, Super Turmeric is rich in antioxidants and is ten times better absorbed by the body, thereby reducing inflammation, and improving the everyday immunity of an individual.
 
Tru Relief is a clinically proven, advanced pain management solution derived from the phytocannabinoids of black pepper and is designed for adults who want to lead an active lifestyle. It provides relief from muscular discomfort, supports recovery from injuries and improves all-round musculoskeletal health. 
 
The Full Spectrum Ginger Extract in Activ Digest has an antimicrobial and anti-inflammatory ability that can help resist and fight bacteria commonly involved in gastrointestinal disorders. It also acts as a digestive stimulant and supports overall digestive health.
 
Available in a jar of 30 capsules, Super Turmeric, Tru Relief and Activ Digest are priced between INR 600 and 700 and can be bought on www.amazon.in and www.pureveda.com.

Abhinav Bindra backed Add Veda, an Ayurveda Wellness Start-Up Sees 300% Growth

Add Veda Life Care, an Ayurveda and wellness start-up, backed by former Ace Shooter Abhinav Bindra and franchise Retail Company, Franchise India, has achieved a 300% growth since the last year. The transforming belief of people in Ayurveda has led to the immense growth of the company. 

Add Veda formulates and manufactures range of Ayurvedic products for health, wellness and beauty. The COVID pandemic has been a blessing in disguise for the start-up as Ayurveda is the most talked about medicine system to boost immunity. The Ayurvedic products of Add Veda are formulated and produced under the expert guidance of Dr. Jogesh Passi, one of the Founders & Director of Add Veda and a practitioner of Ayurveda who has over 35 years of experience in this field. Looking at the market demand, the start-up recently launched 14 new Ayurvedic products with herbs like Ashwagandha, Giloy, Neem, Tulsi, Curcumin, Spirulina, etc., which makes the start-up’s portfolio to 40 proprietary medicines, classical formulations, supplements and cosmetic products.

“We formed Add Veda with the sole objective of providing authentic, pure and effective Ayurvedic formulations, which are natural, chemical-free, healthy solutions for the mind, body and soul. We are into the business for the last 35 years and have observed that over the years people have formed trust in Ayurveda. Our experience enticed us to venture out as a manufacturer and supplier and reach out for the wellbeing of people”, says Dr. Jogesh Passi, Founder & Director, Add Veda.

Initially, Add Veda was selling its products through various digital platforms and leading pharmacy chains in Delhi/NCR, but due to operational issues, the start-up had to switch to digital only model. This model worked out for the start-up, and under the guidance of its investors, former Ace Shooter Abhinav Bindra’s Venture fund, Shooting Star LLP and franchise Retail Company, Franchise India, the start-up started witnessing an upward graph and since then there hasn’t been looking back.

“The online model has been working out very well for us and we see YoY growth of the company. During the past one year, Add Veda has seen its gross revenue growth by over 300%. Riding on the recent uptrend, Add Veda hopes to replicate this growth in the future as well”, says Ankush Passi, Founder & CEO, Add Veda.

About Add Veda

Add Veda was born in the year 2016 and is focused on Ayurveda and wellness products. Growing up, Mr. Ankush Passi, Founder & CEO of the start-up, watched his father, Dr. Jogesh Passi (G.A.M.S.), Founder & Director, caring for his patients at Dr. Passi’s Herbal Research Centre. Dr. Passi’s love for his patients and Ankush’s own interest in all things herbal, was the inspiration behind Add Veda. Add Veda’s guiding philosophy is to take the wisdom of Ayurveda to the world.

Add Veda offers a wide range of Ayurvedic 40 plus proprietary medicines, classical formulations, supplements and cosmetic products, which are formulated under the expert guidance of Dr. Passi and manufactured in a strict quality-controlled environment at its production facility at Ludhiana. All the products are available at e-commerce platforms such as Amazon.in, 1mg.com, Senority.in Lybrate.com, Addveda.com.